Device type · NEK
Filler, Recombinant Human Bone Morphogenetic Protein, Collagen Scaffold With Metal Prosthesis, Osteoinduction
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
NEK
Orthopedic
Device class
Class III
FDA decisions since 2015
1
510(k), De Novo and PMA
Adverse event reports
38
Received Nov 1, 2025 to Nov 20, 2026
How FDA classifies it
- Device type
- Filler, Recombinant Human Bone Morphogenetic Protein, Collagen Scaffold With Metal Prosthesis, Osteoinduction
- Product code
- NEK
- Device class
- Class III
- Review panel
- Orthopedic
- Specialty
- Orthopedic Surgery
- FDA record
- Classification database entry for NEK
Latest FDA decisions
- Infuse Bone GraftBreakthroughPMA supplement
Medtronic Sofamor Danek USA, Inc.
P000058-S096 · Decided Feb 13, 2026 · 178 days after receipt · Panel Track
Device type: Filler, recombinant human bone morphogenetic protein, collagen scaffold with metal prosthesis, osteoinduction (NEK) · Orthopedic Surgery
Reports received
38
Received Nov 1, 2025 to Nov 20, 2026
Malfunction reports
22
58% of reports
Injury reports
16
42% of reports
Death reports
0
0.0% of reports
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 0 | 1 | 0 | 0 |
| Jan 24 | 0 | 0 | 0 | 0 |
| Feb 24 | 1 | 1 | 0 | 0 |
| Mar 24 | 4 | 2 | 0 | 0 |
| Apr 24 | 1 | 7 | 0 | 0 |
| May 24 | 0 | 0 | 0 | 0 |
| Jun 24 | 2 | 2 | 0 | 0 |
| Jul 24 | 2 | 1 | 0 | 0 |
| Aug 24 | 0 | 0 | 0 | 0 |
| Sep 24 | 0 | 1 | 0 | 0 |
| Oct 24 | 0 | 2 | 0 | 0 |
| Nov 24 | 5 | 4 | 0 | 0 |
| Dec 24 | 0 | 1 | 0 | 0 |
| Jan 25 | 0 | 1 | 0 | 0 |
| Feb 25 | 1 | 1 | 0 | 0 |
| Mar 25 | 4 | 1 | 0 | 0 |
| Apr 25 | 3 | 1 | 0 | 0 |
| May 25 | 2 | 9 | 0 | 0 |
| Jun 25 | 3 | 3 | 0 | 0 |
| Jul 25 | 2 | 2 | 0 | 0 |
| Aug 25 | 5 | 2 | 0 | 0 |
| Sep 25 | 2 | 4 | 0 | 0 |
| Oct 25 | 1 | 2 | 0 | 0 |
| Nov 25 | 1 | 1 | 0 | 0 |
| Dec 25 | 1 | 0 | 0 | 0 |
| Jan 26 | 0 | 2 | 0 | 0 |
| Feb 26 | 2 | 0 | 0 | 0 |
| Mar 26 | 4 | 3 | 0 | 0 |
| Apr 26 | 2 | 4 | 0 | 0 |
| May 26 | 2 | 2 | 0 | 0 |
| Jun 26 | 4 | 2 | 0 | 0 |
| Jul 26 | 4 | 0 | 0 | 0 |
| Aug 26 | 0 | 0 | 0 | 0 |
| Sep 26 | 0 | 1 | 0 | 0 |
| Oct 26 | 2 | 1 | 0 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
- Off-Label Use22
- Adverse Event Without Identified Device or Use Problem10
- Osseointegration Problem4
1 more in this ranking with a free account
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
- No Clinical Signs, Symptoms or Conditions15
- Inadequate Osseointegration6
- Nerve Damage4
7 more in this ranking with a free account
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Medtronic Sofamor Danek USA Inc
Z-0440-2019 · Started Sep 27, 2018
Reason given: The Extra Small INFUSE Bone Graft kit from lot M111806AAA, may contain two absorbable collagen sponges (ACS), but should only contain one ACS.
Cause as FDA categorized it: Error in labeling
Medtronic Sofamor Danek USA Inc
Z-1589-2013 · Started May 28, 2013 · Posted by FDA Jun 25, 2013
Reason given: Kits contain a collagen sponge recalled by Integra due to possible elevated endotoxin levels resulting from a process deviation.
Cause as FDA categorized it: Nonconforming Material/Component
Medtronic Sofamor Danek USA Inc
Z-1590-2013 · Started May 28, 2013 · Posted by FDA Jun 25, 2013
Reason given: Kits contain a collagen sponge recalled by Integra due to possible elevated endotoxin levels resulting from a process deviation.
Cause as FDA categorized it: Nonconforming Material/Component
5 more recall records with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.